Pharmafile Logo
Pharmafocus logo
Advanced Search

SHL to attend the 2014 PDA Japan: A collaborative approach to developing combination products

May 13, 2014
Medical Communications auto injector, autoinjectors, pda japan 2014, pen injector, shl pda 2014

Tokyo, Japan – SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that …

News
Press release
Luke arm image

‘Star Wars’ robot arm approved by FDA

May 12, 2014
Manufacturing and Production, Medical Communications, Sales and Marketing FDA, arm, deka arm system, luke, star wars

The FDA has approved a first of its kind robotic arm that can be used to make complex tasks far …

News
Boehringer image

Boehringer launches new transparency regime

May 12, 2014
Research and Development, Sales and Marketing Boehringer, LEO Pharma, all trials, csr, transparency

Boehringer is making good on its 2013 promise to release more clinical trial data to researchers with the launch of …

News
david_cameron_1

AZ ‘consulted first’ by UK government after Pfizer bid

May 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, George Osborne, Pfizer, Wellcome Trust, david cameron

UK prime minister David Cameron has rejected claims that his government is prioritising discussions with Pfizer over its proposed acquisition …

News

Pfizer signs universities deal

May 12, 2014
Research and Development, Sales and Marketing AstraZeneca, Pfizer, academics, rare diseases

Pfizer has signed a five-year research deal with several top British universities to hunt for new treatments for rare disease. …

News
AZ park image

‘Bioscience is cornerstone’ of Alderley Park

May 12, 2014
Research and Development, Sales and Marketing AZ, AstraZeneca, alderley, msp, research

Manchester Science Parks (MSP), the new owners of the 400-acre Alderley Park facility, has pledged to keep its activities “at …

News
Lundbeck image

Lundbeck buys Chelsea Therapeutics

May 12, 2014
Research and Development, Sales and Marketing Chelsea Therapeutics, Lundbeck

Lundbeck could pay as much as $658 million for neurological disorder specialist Chelsea Therapeutics as the firm looks to shore …

News
Riwal image

Clinical trials transparency: the journey so far

May 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, alltrials, rawal, transparency

There has been considerable publicity over the last year or two about transparency of information in clinical trials. However, activity …

Feature
christian_lebbink

Talentmark hires Benelux executive search head

May 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Talentmark, lebbink

Life sciences recruitment firm Talentmark has confirmed Christiaan Lebbink is to join the firm covering the Benelux and continental European region Lebbink, …

Appointment
Merck image

Merck’s vorapaxar gains long-awaited FDA approval

May 9, 2014
Sales and Marketing Boehringer, FDA, Merck, lilly, vorapaxar, zontivity

Merck’s heart drug vorapaxar has finally been given the FDA go-ahead after looking dead in the water less than two …

News
astrazeneca_plaque

AstraZeneca begins lung cancer trial

May 9, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, MEDI4736, NSCLC, lung cancer

AstraZeneca, currently at the centre of a £63 billion bid from US giant Pfizer, has begun a late-stage trial of …

News

Wellcome Trust slams Pfizer/AstraZeneca bid

May 9, 2014
Medical Communications, Sales and Marketing GSK, Pfizer, Read, astrazenca, emms, merger, takeover

The UK’s largest and most respected medical research charity the Wellcome Trust has warned that Pfizer’s potential takeover of AstraZeneca …

News
Sun Pharma image

Latest Sun Pharma recall blow for firm

May 9, 2014
Manufacturing and Production Caraco, Cetirizine, Effexor, FDA, Sun Pharma, recall

India’s largest drugmaker Sun Pharmaceutical Industries is recalling almost 400,000 bottles of anti-depressant and antihistamine medications in the US, because …

News
screen_shot_2014-05-09_at_08

ABPI appoints manager 
from Pfizer


May 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pfizer, christine rowland

The ABPI has appointed Christine Rowland to the newly-created position of value and access manager for its commercial department.  Rowland …

Appointment

NICE recommends Xtandi

May 9, 2014
Sales and Marketing Astellas, NICE, Xtandi, abiraterone, prostate

NICE has reiterated that Astellas Pharma’s Xtandi should be used to treat NHS prostate cancer patients – but has removed …

News
Avastin image

EU looks at eye drug allegations

May 8, 2014
Sales and Marketing EU, Lucentis, Novartis, Roche, avastin, offlabel

European Union regulators are considering whether they need to take any action over the recent allegations of anti-competitiveness involving Roche …

News
3d printing image

3D printed hearts ‘on the horizon’

May 8, 2014
Medical Communications, Sales and Marketing 3D, heart, louisville, printing, williams

The ‘inherent design flaws’ of the human heart could become a thing of the past as new 3D printing technology …

News
daniel_smith_high_res

Cobra Biologics appoints CSO


May 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CSO, cobra biologics, smith

Contract manufacturing organisation Cobra Biologics has hired Dr Daniel Smith as its chief scientific officer. Smith has spent the last …

Appointment
NHS image

RPS: ‘Give pharma incentives’

May 8, 2014
Research and Development, Sales and Marketing NHS, RPS, rare diseases, royal pharmaceutical society

Incentives are urgently required to speed up the development of personalised medicines, according to a new report from the Royal …

News
screen_shot_2014-05-07_at_15

ICON appoints non-executive director

May 7, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ICON, brady

Contract research organisation (CRO) ICON has appointed Dr Hugh Brady as a non-executive director.  Brady previously served as president at …

Appointment
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026